Clinical Trial Update: Caffeine as a Therapy for Parkinson's Disease [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 clinical trial evaluating caffeine as a therapy for Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED